产品名称 | NebuSelect™ Recombinant Human LAIR2/CD306, Avi-His-tag |
---|---|
目录号 | NBL-242386 |
别名 | LAIR2/CD306; LAIR-2; CD306; LAIR2; MGC71634; XXbac-BCX535A19.6 |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q6ISS4-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242386-100ug | 100ug | Inquire | Inquire | |
NBL-242386-1mg | 1mg | Inquire | Inquire | |
NBL-242386-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LAIR2/CD306, Avi-His-tag
Catalog#:
NBL-242386
Description:
NebuSelect™ Recombinant Human LAIR2/CD306, Avi-His-tag(Cat#NBL-242386) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Gln22-Pro152.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 17 kDa. Due to glycosylation, the protein migrates to 20-25 kDa based on Bis-Tris PAGE result.
Target Name:
LAIR2/CD306; LAIR-2; CD306; LAIR2; MGC71634; XXbac-BCX535A19.6
Target Information:
The leukocyte-associated immunoglobulin-like receptor 2 (LAIR2) shows increased expression during pregnancy and its reduced expression is associated with pregnancy complications. Although LAIR2 was expressed in the human placenta villus and decidua in the first trimester of pregnancy, it was not expressed in mouse tissues. Knockdown of LAIR2 markedly improved cell viability and inhibited the invasive ability of HTR8/SVneo cells.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.